What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?

Hematopoietic stem cell transplantation (HSCT) is a potential curative therapy for some patients with hematologic conditions. There are two main types of HSCT. This includes autologous HSCT, for which the stem cells are obtained from the patient, and allogeneic HSCT, for which the stem cells are obt...

Descripción completa

Detalles Bibliográficos
Autores principales: Randolph, Brion V., Ciurea, Stefan O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121262/
http://dx.doi.org/10.1007/978-3-319-74588-6_99
_version_ 1783515162362249216
author Randolph, Brion V.
Ciurea, Stefan O.
author_facet Randolph, Brion V.
Ciurea, Stefan O.
author_sort Randolph, Brion V.
collection PubMed
description Hematopoietic stem cell transplantation (HSCT) is a potential curative therapy for some patients with hematologic conditions. There are two main types of HSCT. This includes autologous HSCT, for which the stem cells are obtained from the patient, and allogeneic HSCT, for which the stem cells are obtained from a related or unrelated donor. The most common indications for autologous stem cell transplant are multiple myeloma and relapsed/refractory lymphoma, whereas leukemia and bone marrow failure syndromes remain the most common indications for allogeneic stem cell transplant. This chapter will review the different types, indications, processes, and main complications of HSCT. This chapter will also discuss end-of-life issues that patients and providers face when transplant patients are admitted for the intensive care unit.
format Online
Article
Text
id pubmed-7121262
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-71212622020-04-06 What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation? Randolph, Brion V. Ciurea, Stefan O. Oncologic Critical Care Article Hematopoietic stem cell transplantation (HSCT) is a potential curative therapy for some patients with hematologic conditions. There are two main types of HSCT. This includes autologous HSCT, for which the stem cells are obtained from the patient, and allogeneic HSCT, for which the stem cells are obtained from a related or unrelated donor. The most common indications for autologous stem cell transplant are multiple myeloma and relapsed/refractory lymphoma, whereas leukemia and bone marrow failure syndromes remain the most common indications for allogeneic stem cell transplant. This chapter will review the different types, indications, processes, and main complications of HSCT. This chapter will also discuss end-of-life issues that patients and providers face when transplant patients are admitted for the intensive care unit. 2019-07-09 /pmc/articles/PMC7121262/ http://dx.doi.org/10.1007/978-3-319-74588-6_99 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Randolph, Brion V.
Ciurea, Stefan O.
What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title_full What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title_fullStr What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title_full_unstemmed What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title_short What the Intensivist Needs to Know About Hematopoietic Stem Cell Transplantation?
title_sort what the intensivist needs to know about hematopoietic stem cell transplantation?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7121262/
http://dx.doi.org/10.1007/978-3-319-74588-6_99
work_keys_str_mv AT randolphbrionv whattheintensivistneedstoknowabouthematopoieticstemcelltransplantation
AT ciureastefano whattheintensivistneedstoknowabouthematopoieticstemcelltransplantation

Ejemplares similares